ATS Medical 8-K 2009
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
ATS Medical, Inc.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Item 8.01 Other Events.
On April 27, 2009, ATS Medical, Inc. (the "Company") issued a press release to announce the appointment of Michael E. Reinhardt to the position of Vice President of Marketing effective May 4, 2009. Mr. Reinhardt will be an executive officer of the Company. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
99.1 Press Release of ATS Medical, Inc. dated April 27, 2009.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.